Kissei partnership drives international sales of TAVALISSE, Rigel received $5 million from Grifols, and VEPPANU received FDA approval.
2 reports, 2 independent
Updated Aug 18
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Kissei partnership drives international sales of TAVALISSE, Rigel received $5 million from Grifols, and VEPPANU received FDA approval.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Rigel partnered with Pfizer, leading to FDA approval and market availability of Veppanu.1 source
Kissei sales increase, Rigel gets funding from Grifols, and VEPPANU receives FDA approval.1 source